NetraMark Holdings IncCanadian Securities Exchange:AIAIView on OTCQB
- LAST PRICE0.3050
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.3050/ 10
- Ask / Lots0.3100/ 65
- Open / Previous Close0.0000 / 0.3050
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
NetraMark Holdings Inc | 20.6M | -1.3x | --- |
Totally Hip Technologies Inc | 19.0M | 369.0x | --- |
FRNT Financial Inc | 20.0M | -11.7x | --- |
Resaas Services Inc | 23.2M | -9.7x | --- |
Acceleware Ltd | 17.2M | -8.2x | --- |
AGEDB Technology Ltd | 25.8M | -8.7x | --- |
Company Information
NetraMark Holdings Inc. is a Canada-based company, which is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions targeted at the pharmaceutical industry. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.
Contact Information
- Headquarters
- Suite 101 - 1655 Dupont StreetToronto, ON, Canada M6P 3T1
- Phone
- 647-223-7165
- Fax
- ---
Executives
- Independent Chairman of the Board
- Kevin Taylor
- President, Chief Executive Officer
- George Achilleos
- Chief Financial Officer
- Swapan Kakumanu
- President of NetraMark Corp
- Josh Spiegel
- Chief Scientific Officer, Director
- Joseph Geraci
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $20.6M |
|---|---|
Revenue (TTM) | $88.8K |
Shares Outstanding | 67.4M |
NetraMark Holdings Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.24 |
Book Value | $0.02 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 231.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -14,568.73% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
